Samaan Rafeq
Papers
3
Total Citations
32
H-Index
2
About
Dr. Samaan Rafeq is a leading interventional pulmonologist whose research centers on advancing minimally invasive diagnostic techniques for lung cancer and pulmonary diseases. His most significant contributions lie in the rigorous evaluation of robotic-assisted bronchoscopy, a cutting-edge technology that enhances the precision and safety of lung nodule biopsies. Dr. Rafeq is the principal investigator of the landmark TARGET trial, a prospective, multicenter study that has produced the highest-impact evidence in this field. His seminal 2025 paper, with 27 citations, demonstrated the safety and diagnostic yield of robotic bronchoscopy, establishing new standards for patient care. Earlier reports from the TARGET study, including safety analyses and multicenter outcomes, have further solidified his reputation as a key voice in real-world evidence generation. Through his work, Dr. Rafeq has directly shaped clinical guidelines and provided the data needed for wider adoption of robotic platforms, ultimately improving diagnostic accuracy while reducing procedural risks for patients with suspicious lung lesions.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3